Misunderstandings of Venous thromboembolism prophylaxis
|
|
- Evan Tate
- 6 years ago
- Views:
Transcription
1 Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore
2 Case scenario Madam TAA is a 5' 3," 100kg 58 yo female She is admitted to have a right total knee replacement. Her past medical history includes hypertension and moderate COPD. No personal and family history of VTE. Her home medications include hydrochlorothiazide 25 mg po daily, spiriva and albuterol. She has stopped smoking 1 year ago.
3 Question 1 1. Which of following is NOT a known risk factor for VTE development for Madam TAA? a. Obesity. b. Hypertension. c. COPD. d. Total knee replacement surgery. e. Age 58 years
4 Question 2 2. What is the minimum amount of time Madam TAA should receive VTE prophylaxis? a. 2 days. b. 3 days. c. 5 days. d. 7 days. e. 10 days.
5 VTE = spectrum of DVT + PE Common clinical problem. Significant morbidity and mortality. Major impact on one s health. Economic burden on healthcare system.
6 VTE - Pathophysiology VTE is a complex (multifactorial) disease, involving interactions between various risk factors. Stasis Alteration in normal blood flow VIRCHOW S TRIAD Endothelial Injury Injury or trauma to the inside of the blood vessel Hypercoagulability Alternation in the constitution of blood causing blood to clot more easily
7 VTE - Incidence Annual incidence of VTE in general population 104 to 183 per 100,000 person-years Males 130 per 100,000 person-years Females 110 per 100,000 person years Arch Intern Med. 1998; 158(6): VTE prophylaxis Identify patients who are at increased risk of VTE.
8 Assessing VTE Risk Who should be assessed? ALL adult patients admitted into hospital Others: Preadmission for elective surgery Patient Groups Patients discharged from ED with significantly reduced mobility relative to normal state eg in a cast/boot following lower leg injury Pregnant and post-partum women
9 Outpatient and Inpatient VTE are Linked 74% of VTEs present in outpatients. 26% of VTEs present in in-patients. 42% of outpatient VTE patients have had recent surgery or hospitalization. Spencer FA, et al. Arch Intern Med 2007; 167:
10 Misunderstandings of VTE prophylaxis Unfortunately, VTE prophylaxis for high risk hospitalized patients is extremely underutilized due to historical misconceptions. 1. the belief that the overall incidence of VTE among hospitalized and postoperative patients is too low to consider prophylaxis; 2. fear of bleeding from anticoagulants; 3.unawareness that prophylaxis is effective at decreasing VTE-associated morbidity and mortality; 4. unawareness that broad application of prophylaxis may be cost-effective; and 5. perceptions that VTE is not a significant problem in their practice. 6. the belief that risk of VTE is limited to in-patient stay and doesn t extend into out-pt setting.
11 Misunderstanding 1. Overall incidence of VTE is too low to consider prophylaxis Incidence of VTE without prophylaxis 10 to 40% of medical or surgical hospitalised patients 40 to 60% following major orthopedic surgery. It has been estimated that 10% of hospital deaths are due to pulmonary embolism. Chest. 2004;126:338S 400S. Therefore, VTE is considered the number one cause of preventable death among hospitalized patients.
12
13 Misunderstanding 2. Fear of bleeding from anticoagulation Bleeding is viewed as an act of Commission. Development of VTE is not viewed as an act of Omission.
14
15
16 Misunderstanding 3. Broad application of VTE prophylaxis is expensive
17 Misunderstanding 3. Broad application of VTE prophylaxis is expensive In a population-based study, adjusted mean predicted costs over 5 years were found to be 2.5-fold higher for patients with VTE related to current or recent hospitalization for acute illness (US$62,838) than for hospitalized control patients ($24,464; P <0.001). Cost differences between cases and controls were greatest ($16,897) within the first 3 months. Am. J. Manag. Care. 2015;21:e255 e263
18 Misunderstanding 3. Broad application of VTE prophylaxis is expensive Similarly, the 5-year costs were predicted to be 1.5-fold higher for patients with VTE related to current or recent hospitalization for major surgery ($55,956) than for hospitalized control patients matched by the type of surgery ($32,718; P <0.001). Cost differences between cases and controls were again greatest ($12,381) in the first 3 months after the index date. Surgery. 2015;157:
19 Misunderstanding 4. VTE is not a significant problem in Asia Singapore studies suggest that VTE risk is increasing in our hospitalised patients % ( ) 0.158% ( ) 0.454% ( )
20 Misunderstanding 5. VTE risk ends upon discharge from hospital VTE can occur for up to 3 months after total knee and hip arthroplasty 1 Hypercoagulability can persist for 4-6 weeks after hip fracture 2 Venous function was significantly impaired for up to 35 days following hip fracture surgery 3 1. White RH et al. Arch Intern Med. 1998;158: Wilson D et al. Injury. 2001;32: Wilson D et al. Injury. 2002;33:33-39.
21 Misunderstanding 6. Unaware that prophylaxis is effective in preventing VTE VTE Prophylaxis in 19,958 Medical Patients/ 9 Studies (Meta-Analysis) 62% reduction in fatal PE 57% reduction in fatal or nonfatal PE 53% reduction in DVT Dentali F, et al. Ann Intern Med 2007; 146:
22
23 VTE prophylaxis - Conceptual Framework All hospitalized patients must be routinely evaluated for VTE prophylaxis on admission. Patients should be reassessed within 24 hours of admission and whenever the clinical situation changes. All surgical patients, and all medical patients with significantly reduced mobility, should be considered for further risk assessment. VTE pharmacoprophylaxis involves a tradeoff between preventing thrombosis and causing bleeding When making tradeoffs, need to compare absolute risks of thrombosis and bleeding - VTE risk assessment - Bleeding risk assessment
24 VTE risk assessment models No consensus on what is best in clinical practice Individualized point-based scoring (quantitative) models Generally more rigorously validated in determining risk, but not in clinical practice Examples: Caprini Padua IMPROVE Grouping or bucket models Generally not as well validated in predicting risk, but easier to implement, Examples: NICE / NHS guidelines, Australia / New Zealand working group model Classic 3 bucket model Updated 3 bucket grouping model Although there are many tools for assessing thromboembolism risk, there is insufficient evidence to recommend one over the others. 13
25 Padua Prediction Score Padua Prediction Score one of the most validated prediction tool for assessment of VTE risk in medical patients. Score < 4 Low VTE risk, 0.3% risk of developing symptomatic VTE within 90 days. Score > 4 - High VTE risk, 11% risk of developing symptomatic VTE within 90 days. Cannot apply for critically ill patients.
26
27 Caprini VTE Risk Assessment tool
28 14
29 Updated 3 bucket Model More c/w AT9 guidelines
30 Bleeding risk assessment models
31 Pharmacological Prophylaxis Drug Class Unfractionated heparin LMWH Agents Unfractionated heparin Enoxaparin Dalteparin Preferred in patients with renal impairment Most commonly used agents Require dosage adjustment in renal impairment Factor Xa inhibitors Direct thrombin inhibitors Apixaban Rivaroxaban Fondaparinux Dabigatran Alternative for prophylaxis in post- hip or knee replacement Alternative for prophylaxis in post- hip or knee replacement and hip fracture surgery Alternative for prophylaxis in prophylaxis posthip or knee replacement Heparinoid Danaparoid Used in heparin-sensitivity or HIT
32 Pharmacological Prophylaxis Contraindications may include: Contraindications Active bleeding Thrombocytopenia (platelets < 50 x 10 9 /L) End stage liver disease (INR > 1.5) Treatment with therapeutic anticoagulant e.g. warfarin with INR > 2 Severe trauma to head or spinal cord, with haemorrhage in last 4 weeks
33 Mechanical Prophylaxis Devices that increase blood flow velocity in leg veins, reducing venous stasis. Device Graduated Compression Stockings (GCS) Anti-embolic Stocking Intermittent Pneumatic Compression Device (IPC) Foot Impulse Device (FID) Provide graduated compression, which is firmest at the ankle. Used mainly for ambulant patients Standard compression throughout. Used for bedbound or non-ambulant patients Inflatable garment wrapped around legs which is inflated by pneumatic pump. Enhances venous return Stimulates legs veins to mimic walking and reduce stasis. Used for immobilised patients
34 Mechanical Prophylaxis Contraindications may include: Contraindications Skin ulceration Lower leg trauma Morbid obesity (where correct fitting of stocking cannot be achieved) Massive leg oedema or pulmonary oedema due to CCF Stroke patients (avoid compression stockings) Significant PAD cannot use IPCs
35
36 Case scenario Madam TAA is a 5' 3," 100kg 58 yo female She is admitted to have a right total knee replacement. Her past medical history includes hypertension and moderate COPD. No personal and family history of VTE. Her home medications include hydrochlorothiazide 25 mg po daily, spiriva and albuterol. She has stopped smoking 1 year ago.
37 Question 1 1. Which of following is NOT a known risk factor for VTE development for Madam TAA? a. Obesity. b. Hypertension. c. COPD. d. Total knee replacement surgery. e. Age 58 years
38 Question 1 1. Which of following is NOT a known risk factor for VTE development for Madam TAA? a. Obesity. b. Hypertension. c. COPD. d. Total knee replacement surgery. e. Age 58 years
39 Question 2 2. What is the minimum amount of time Madam TAA should receive VTE prophylaxis? a. 2 days. b. 3 days. c. 5 days. d. 7 days. e. 10 days.
40 Question 2 2. What is the minimum amount of time Madam TAA should receive VTE prophylaxis? a. 2 days. b. 3 days. c. 5 days. d. 7 days. e. 10 days.
41 Conclusions VTE prophylaxis is justified, low-risk, and indicated in most hospitalized patients. Overall, VTE prophylaxis is under-utilized. Physician hesitation is due to misunderstandings. Appropriate prophylaxis should be delivered for an appropriate duration. Each hospital needs a standardized approach for VTE prophylaxis to improve compliance protocols, pre-printed orders, risk stratification, etc. Multi-disciplinary approach auditing
42 Thankyou for your kind attention
Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales
Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital
More informationDVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center
DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the
More informationVenous Thromboembolism. Prevention
Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and
More informationVenous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital
Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital VTE is common and dangerous 5 VTE is Common VTE Incidence: 1.5 / 1000 per year
More informationTHROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY
THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY OBJECTIVE: To outline a practical approach for the prevention of venous thromboembolism (VTE) in patients undergoing non-orthopedic surgery. BACKGROUND: VTE is
More informationVenous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
More informationPrevention of Venous Thromboembolism
Prevention of Venous Thromboembolism Surgical Care Improvement Project Dale W. Bratzler, DO, MPH President and CEO Dale W. Bratzler, DO, MPH Oklahoma Foundation for Medical Quality QIOSC Medical Director
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE VENOUS THROMBOEMBOLISM PROPHYLAXIS SCOPE Provincial Acute and Sub-Acute Care Facilities APPROVAL AUTHORITY Alberta Health Services Executive Committee SPONSOR Vice President, Quality and Chief Medical
More informationObjectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?
Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP
More informationSlide 1. Slide 2. Slide 3. Outline of This Presentation
Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous
More informationVTE Management in Surgical Patients: Optimizing Prophylaxis Strategies
VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE in Surgical Patients: Recognizing the Patients at Risk Pathogenesis of thrombosis: Virchow s triad and VTE Risk Hypercoagulability
More informationINDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY
INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism
More informationAnticoagulation for prevention of venous thromboembolism
Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines
More informationVenous thromboembolism - reducing the risk
Venous thromboembolism - reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital NICE guideline Draft for consultation,
More informationVenous Thromboembolism Prophylaxis: Checked!
Venous Thromboembolism Prophylaxis: Checked! William Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead, VTE Prevention, Safer
More informationGetting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis
Reducing Harm Improving Healthcare Protecting Canadians VENOUS THROMBOEMBOLISM PREVENTION Getting Started Kit Section 2: Evidence-Based Appropriate VTE Prophylaxis January 2017 www.patientsafetyinstitute.ca
More informationEarly Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN
Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,
More informationVenous thromboembolism: reducing the risk
Issue date: January 2010 Venous thromboembolism: reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital This guideline
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationThese are guidelines only and can be deviated from if it is thought to be in the patient s best interest.
Clinical Guideline Venothromboembolism prophylaxis: Trauma and Orthopaedics Venous thromboembolism (VTE) is a recognised complication associated with inactivity and surgical procedures. Therefore, all
More informationThe Royal College of Emergency Medicine. VTE Risk in Lower Limb Immobilisation in Plaster Cast 2015/2016
The Royal College of Emergency Medicine Clinical Audits VTE Risk in Lower Limb Immobilisation in Plaster Cast Introduction 2015/2016 EXCELLENCE IN EMERGENCY MEDICINE A significant number of patients attend
More informationVenothromboembolism prophylaxis: Trauma and Orthopaedics Clinical guideline, V2
Clinical Guideline Venothromboembolism prophylaxis: Trauma and Orthopaedics 11/11/11 TEMPORARY GUIDANCE There is no prophylactic tinzaparin available in the Trust currently. Please substitute enoxaparin
More informationPerioperative VTE Prophylaxis
Perioperative VTE Prophylaxis Gregory J. Misky, M.D. Assistant Professor of Medicine University Of Colorado Denver You recommend the following 72 y.o. man admitted for an elective R hip repair. Patient
More informationVenous Thromboembolism National Hospital Inpatient Quality Measures
Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation
More informationVenous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital
Please Note: This policy is currently under review and is still fit for purpose. Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital This procedural document supersedes
More informationCPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593
Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2015 PQRS OPTIONS FOR INDIVIDUAL MEASURES:
More informationDENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients
Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES:
More informationCANCER ASSOCIATED THROMBOSIS. Pankaj Handa Department of General Medicine Tan Tock Seng Hospital
CANCER ASSOCIATED THROMBOSIS Pankaj Handa Department of General Medicine Tan Tock Seng Hospital My Talk Today 1.Introduction 2. Are All Cancer Patients at Risk of VTE? 3. Should All VTE Patients Be Screened
More informationComparison of Venothromboembolism Prophylaxis Practices in a Winnipeg Tertiary Care Hospital to Chest Guidelines: A Quality Improvement Project
Comparison of Venothromboembolism Prophylaxis Practices in a Winnipeg Tertiary Care Hospital to Chest Guidelines: A Quality Improvement Project Dr. Jonathan Laxton, FRCPC, R5 GIM University of Manitoba
More informationGUIDELINE FOR THROMBOPROPHYLAXIS IN ADULT (18 YEARS AND OLDER) IN GENERAL MEDICAL PATIENTS AND INPATIENTS UNDERGOING SURGERY
GUIDELINE FOR THROMBOPROPHYLAXIS IN ADULT (18 YEARS AND OLDER) IN GENERAL MEDICAL PATIENTS AND INPATIENTS UNDERGOING SURGERY SEE SEPARATE GUIDELINES FOR THROMBOPROPHYLAXIS IN OBSTETRICS This guidance does
More information10/8/2012. Disclosures. Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines. Goals and Objectives. Outline
Disclosures Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines No relevant conflicts of interest related to the topic presented. Cyndy Brocklebank, PharmD, CDE Chronic Disease Management
More informationWhat evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?
July 2015 Rapid Review Evidence Summary McGill University Health Centre: Division of Nursing Research and MUHC Libraries What evidence exists that describes the efficacy of mechanical prophylaxis for venous
More informationHospital Acquired VTE: update on national guidance
Hospital Acquired VTE: update on national guidance Rebecca Chanda Consultant Pharmacist - Thrombosis and Haemostasis Guy s and St Thomas Hospitals NHS Foundation Trust Chair of the UK Clinical Pharmacy
More informationNICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1
The College of Emergency Medicine Patron: HRH The Princess Royal Churchill House Tel +44 (0)207 404 1999 35 Red Lion Square Fax +44 (0)207 067 1267 London WC1R 4SG www.collemergencymed.ac.uk CLINICAL EFFECTIVENESS
More information*Corresponding Author:
Audit of venous thromboembolism prophylaxis administered to general surgical patients undergoing elective and emergency operations at National Hospital, Sri Lanka *Migara Seneviratne 1, Asanka Hemachandra
More informationEXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS
EXTENDING VTE PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS Samuel Z. Goldhaber, MD Director, VTE Research Group Cardiovascular Division Brigham and Women s Hospital Professor of Medicine Harvard Medical
More informationLow Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders
SURGICAL GRAND ROUNDS March 17 th, 2007 Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders Guillermo Escobar, M.D. LMWH vs UFH Jayer s sales pitch: FALSE LMW is
More informationNICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89 NICE 2018. All rights
More informationDr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton
Dr. Steve Ligertwood Hospitalist Royal Columbian Hospital Regional Department Head-Hospitalist for Fraser Health Authority Project Lead BC Hospitalist VTE Collaborative Clinical Instructor, UBC School
More informationAdam Goldfarb, M.A., D.C., D.E.S.S. Introduction
Venous Thromboembolism Prophylaxis following Lower Extremity Orthopedic Surgery: A Review of the Biomedical Research Literature and Evidence-Based Policy in the United States. Adam Goldfarb, M.A., D.C.,
More informationMedical Patients: A Population at Risk
Case Vignette A 68-year-old woman with obesity was admitted to the Medical Service with COPD and pneumonia and was treated with oral corticosteroids, bronchodilators, and antibiotics. She responded well
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationPREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational
More informationWhat You Should Know
1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society
More informationPostsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
Clinical Position Statement Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Effective: October 2017 Next Review: September 2018 CLINICAL POSITION STATEMENT Postsurgical
More informationNew v1.0 Date: December 2015 Patricia Wain - Associate Director Physical Care. Kenny Laing - Deputy Director of Nursing
Clinical Venous Thromboembolism: Standing Operating Procedure Document Control Summary Status: Version: Author/Title: Owner/Title: New v1.0 Date: December 2015 Patricia Wain - Associate Director Physical
More informationMeasurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI
Measurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI Hospitals For hospitals in the United States, measures of cardiovascular care mandated by the Joint Commission have recently
More informationDeep Vein Thrombosis
Deep Vein Thrombosis from NHS (UK) guidelines Introduction Deep vein thrombosis (DVT) is a blood clot in one of the deep veins in the body. Blood clots that develop in a vein are also known as venous thrombosis.
More informationVTE Prophylaxis. Serving an unmet need in high-risk acute stroke patients.
VTE Prophylaxis Serving an unmet need in high-risk acute stroke patients www.gekodevices.com Providing venous thromboembolism (VTE) prophylaxis to at-risk stroke patients The risk of venous thromboembolism
More informationObesity, renal failure, HIT: which anticoagulant to use?
Obesity, renal failure, HIT: which anticoagulant to use? Mark Crowther with thanks to Dr David Garcia and others. This Photo by Unknown Author is licensed under CC BY-SA 1 2 Drug choices The DOACs have
More informationNoCVA Hospital Engagement Network SSI/VTE Safe Surgery Collaborative. December 13, 2012
NoCVA Hospital Engagement Network SSI/VTE Safe Surgery Collaborative December 13, 2012 1 Hospital Acquired VTE Preventing a Preventable Problem It takes a commitment from ALL members of the healthcare
More informationDVT - initial management NSCCG
Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis
More informationCHAPTER 2 VENOUS THROMBOEMBOLISM
CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology
More informationPage: 1 of 13. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
Last Review Status/Date: March 2014 Page: 1 of 13 Compression Devices for Venous Description Patients undergoing major orthopedic surgery are at increased risk for venous thromboembolism (VTE). Patients
More informationFatal P.E. Historic 1-2% Current %
Dr. (Prof.) Anil Arora MS (Ortho) DNB (Ortho) Dip SIROT (USA) FAPOA (Korea), FIGOF (Germany), FJOA (Japan) Commonwealth Fellow Joint Replacement (Royal National Orthopaedic Hospital, London, UK) Senior
More informationDVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness
More informationVTE Prevention Guidelines (Venous Thromboembolism) (Venous Thromboembolism)
VTE Prevention Guidelines (Venous Thromboembolism) (Venous Thromboembolism) When using this document please ensure that the version you are using is the most up to date either by checking on the Trust
More informationVenous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community
Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer
More informationReducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge
Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein
More informationCancer and Thrombosis
Cancer and Thrombosis The close relationship between venous thromboembolism and cancer has been known since at least the 19th century by Armand Trousseau. Thrombosis is a major cause of morbidity and mortality
More informationVTE in the Trauma Population
VTE in the Trauma Population Erik Peltz, D.O. February 11 th, 2015 * contributions from Eduardo Gonzalez, M.D. University of Colorado T-32 Research Fellow The problem. VTE - Scope of the Problem One of
More informationGeneral. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations
General Guideline Title Prevention of deep vein thrombosis and pulmonary embolism. Bibliographic Source(s) American College of Obstetricians and Gynecologists (ACOG). Prevention of deep vein thrombosis
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationPage: 1 of 14. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
Subject: Post-Surgical Outpatient Use of Limb Page: 1 of 14 Last Review Status/Date: March 2015 Post-Surgical Outpatient Use of Limb Compression Devices for Venous Description Patients undergoing major
More informationNational Institute for Health and Clinical Excellence Health Technology Appraisal
National Institute for Health and Clinical Excellence Health Technology Appraisal Rivaroxaban for the prevention of venous thromboembolism after elective orthopaedic surgery of the lower limbs Comment
More informationProphylaxis for Hospitalized and Non-Hospitalized Medical Patients
Prophylaxis for Hospitalized and Non-Hospitalized Medical Patients An Educational Slide Set American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism Slide set authors: Eric
More informationJessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks
Jessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks 1. What is the most common cause of death in hospitalized patients? 1. Hospital-acquired infection 2. Pulmonary embolism 3. Myocardial infarction
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Postsurgical Home Use of Limb Compression Devices Page 1 of 20 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See Also: Postsurgical Home Use of Limb Compression
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationDraft. These draft recommendations are not final and therefore are not intended for use or citation.
ASH Recommendations for VTE in Non-Surgical Patients INTRODUCTION American Society of Hematology (ASH) guidelines are based on a systematic review of available evidence. Through a structured process, a
More informationGuideline Quick View: Venous Thromboembolism
Guideline Quick View: Venous Thromboembolism The AORN Guideline Quick View is a key component of Guideline Essentials, a suite of online implementation tools designed to help the perioperative team translate
More informationWith All the New Drugs, This is How I Treat Acute DVT and Superficial Phlebitis
BRIGHAM AND WOMEN S HOSPITAL With All the New Drugs, This is How I Treat Acute DVT and Superficial Phlebitis Gregory Piazza, MD, MS Division of Cardiovascular Medicine Brigham and Women s Hospital April
More informationDeep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H
Deep vein thrombosis and its prevention in critically ill adults Attia J, Ray J G, Cook D J, Douketis J, Ginsberg J S, Geerts W H Authors' objectives To systematically review the incidence of deep vein
More informationLIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS
PROPHYLAXIS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent
More informationASHP Therapeutic Position Statement on the Role of Pharmacotherapy in Preventing Venous Thromboembolism in Hospitalized Patients
ASHP Therapeutic Position Statements 599 ASHP Therapeutic Position Statement on the Role of Pharmacotherapy in Preventing Venous Thromboembolism in Hospitalized Patients Position Hospitals should develop
More informationCorporate Medical Policy
Corporate Medical Policy Postsurgical Home Use of Limb Compression Devices for Venous File Name: Origination: Last CAP Review: Next CAP Review: Last Review: postsurgical_home_use_of_limb_ compression_devices_for_vte_prophylaxis
More informationPrimary VTE Prophylaxis. Ponlapat Rojnuckarin, MD PhD Chulalongkorn University Bangkok, Thailand
Primary VTE Prophylaxis Ponlapat Rojnuckarin, MD PhD Chulalongkorn University Bangkok, Thailand A 70-yr-old female before THA BMI 31 kg/m 2 with varicose vein What do you recommend for VTE prevention?
More informationSUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS
MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
More informationCADTH Rapid Response Report: ASA for Venous Thromboembolism Prophylaxis: Evidence for Clinical Benefit and Harm
CADTH Rapid Response Report: ASA for Venous Thromboembolism Prophylaxis: Evidence for Clinical Benefit and Harm P. Timothy Pollak, MD, PhD University of Calgary Rocky Mountain/ACP Internal Medicine Meeting,
More informationADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4
TELEMETRY BED TRANSFER 1 of 4 9 Actual 9 Estimated Patient ID Area Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Transfer to: 10 South Attending Physician: Diagnosis:
More informationPrevention of Venous Thromboembolism
Prevention of Venous Thromboembolism Reference No: P_CS_05 Version 2.4 Ratified by: LCHS Trust Board Date ratified: 27 th January 2015 Name of originator / author: Medical Director Name of responsible
More informationTarkten A Pharr, MD, FACS 04/26/2018. VTE Prevention Strategies: Is a One Size Fits all Approach Correct?
Tarkten A Pharr, MD, FACS 04/26/2018 VTE Prevention Strategies: Is a One Size Fits all Approach No disclosures... Why do we care? Where is this is the realm of public health concerns? Incidence/Prevalence
More informationTHROMBOSIS RISK FACTOR ASSESSMENT
Name: Procedure: Doctor: Date: THROMBOSIS RISK FACTOR ASSESSMENT CHOOSE ALL THAT APPLY EACH RISK FACTOR REPRESENTS 1 POINT Age 41 60 years Minor Surgery Planned History of Prior Major Surgery (< 1 month)
More informationSUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14, 09/15/15,09/21/17. THROMBOEMBOLISM PROPHYLAXIS
MEDICAL POLICY REVISED DATE: 06/26/14, 09/15/15,09/21/17. PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,
More informationTo prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)
To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) after hip or knee replacement surgery Always read the
More informationPerioperative VTE prophylaxis (ACCP 9 th edition Guidelines) Gamal Marey SUNY Downstate Medical Center 10/16/2014
Perioperative VTE prophylaxis (ACCP 9 th edition Guidelines) Gamal Marey SUNY Downstate Medical Center 10/16/2014 Case Presentation 75 y/o AAM Rectal bleeding & obstructive symptoms 11/12 Obstructing mass
More informationAre guidelines for anticoagulation useful in cancer patients?
Session 3 Striking a Balance Between Bleeding and the Risk of Thrombosis in Cancer Patients Are guidelines for anticoagulation useful in cancer patients? Sebastian Szmit Department of Pulmonary Circulation
More informationPostsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis
Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Policy Number: 1.01.28 Last Review: 4/2018 Origination: 4/2013 Next Review: 4/2019 Policy Blue Cross and Blue
More informationThromboprophylaxis Guidelines for Adult Patients in: Medicine, Haematology & Oncology, Intensive Care Unit, Surgery, Orthopaedics, Major Trauma.
2015 Thromboprophylaxis Guidelines for Adult Patients in: Medicine, Haematology & Oncology, Intensive Care Unit, Surgery, Orthopaedics, Major Trauma. Title Thromboprophylaxis guidelines for adult patients
More informationClinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:
Clinical Policy: (Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 02.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationPreventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy
Preventing blood clots while you are in hospital and after you leave Information for patients Pharmacy Why does blood clot? When we cut ourselves, we bleed. To stop us from bleeding too much, chemicals
More informationHow to prevent blood clots whilst in hospital and after your return home
How to prevent blood clots whilst in hospital and after your return home Patient information WHAT What IS is DEEP deep VEIN vein THROMBOSIS? thrombosis? Deep Vein Thrombosis DVT is a blood clot within
More informationDOAC and NOAC are terms for a novel class of directly acting oral anticoagulant drugs including Rivaroxaban, Apixaban, Edoxaban, and Dabigatran.
Guideline for Patients on Direct Oral Anticoagulant Therapy Requiring Urgent Surgery for Hip Fracture Trust Ref:C10/2017 1. Introduction This guideline is for the clinical management of patients on direct
More informationUnderstanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal
Understanding thrombosis in venous thromboembolism João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Disclosures João Morais On the last year JM received honoraria
More informationTHROMBOPROPHYLAXIS POLICY FOR ADULT PATIENTS ADMITTED AS INPATIENTS. 362 Version No: 2 Previous Trust / LHB Ref No:
Reference No: THROMBOPROPHYLAXIS POLICY FOR ADULT PATIENTS ADMITTED AS INPATIENTS 362 Version No: 2 Previous Trust / LHB Ref No: 362 Documents to read alongside this Policy, Procedure etc (delete as necessary)
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationVenous Thromboembolism (VTE) Prevention
Venous Thromboembolism (VTE) Prevention 7 VTE Risk Assessment: General Patient Population Assess VTE risk at admission, post-op, and transfer See page 2 for VTE risk assessment among Obstetrical (OB) patients
More information